“…Frailty assessment should be mandatory in patients presenting a NST-ACS, as it is a powerful predictor of poor outcomes, with higher mortality and readmissions (22), though there is uncertainty about the most appropriate management regarding invasive coronary intervention in frail elderly patients (23). However, it is not routinely measured in daily clinical practice (19), and was not taken into account in the work of Sui et al (11). It is uncertain whether the differences in treatment response by sex are explained by biological factors and gender particularities per se, or inequity in the administration of therapies and patients' selection.…”